Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain.
Clinical trial NCT04704453 · COMPLETED
Trial details
- NCT number
- NCT04704453
- Sponsor
- Institut Claudius Regaud
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2025-04-28
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.